Compositions And Methods For Treating Malaria
US Application 63/140,308
Filed on 2021-01-22
Filed on 2021-01-22
EPSTEIN-BARR VIRUS GLYCOPROTEIN 42 IMMUNOGENS FOR VACCINATION AND ANTIBODY DISCOVERY
US Application 63/482,143
Filed on 2023-01-30
Filed on 2023-01-30
Novel Compositions Of Matter Comprising Pfs230 Malaria Vaccine Antigens And Anti-Pfs230 Monoclonal Antibodies And Their Use
US Application 63/368,739
Filed on 2022-07-18
Filed on 2022-07-18
Engineered SARS-CoV-2 Antibodies With Increased Neutralization Breadth
US Application 63/404,473
Filed on 2022-09-07
Filed on 2022-09-07
Multi Protein Nanoparticle Monkeypox Vaccine
US Application 63/402,702
Filed on 2022-08-31
Filed on 2022-08-31
Self-assembling Nanoparticles Based On Amphiphilic Peptides For Intravenous Drug Delivery
US Application 63/284,375
Filed on 2021-11-30
Filed on 2021-11-30
RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN
US Application 63/502,829
Filed on 2023-05-17
Filed on 2023-05-17
Monoclonal Antibodies that bind to the underside of Influenza Viral Neuraminidase
US Application 63/394,243
Filed on 2022-08-01
Filed on 2022-08-01
SARS-CoV-2 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRUS-INDUCED AIRWAY FIBROSIS
US Application 63/388,498
Filed on 2022-07-12
Filed on 2022-07-12
METHOD OF IMMUNOFOCUSING AN IMMUNE RESPONSE
US Application 63/369,909
Filed on 2022-07-29
Filed on 2022-07-29